Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin nasal drops for post COVID-19 parosmia
NCT05269030Phase 2Unknown
- Sponsor
- Menoufia University
- Start
- Jul 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ivermectin in parosmia, sponsored by Menoufia University. Status: unknown.
02
Drugs
ivermectin
03
Conditions
parosmia
Beyond the preview
Go deeper on NCT05269030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05269030.